Described herein are compositions and methods for the inhibition of miR 21 activity. The compositions have certain nucleoside modification patterns that yield potent inhibitors of miR 21 activity. The compositions may be used to inhibit miR 21 and also to treat diseases associated with abnormal expression of miR 21 such as fibrosis and cancer.